M&A / Deals Lilly puts up to $2.75bn into Insilico alliance PharmaphorumInsilico has once again added to its roster of big pharma partners, signing a deal with Eli Lilly that includes a $115m upfront payment.M&A / DealsRead full story pharminent March 29, 2026 (Last updated: March 30, 2026) Pharmaphorum Insilico has once again added to its roster of big pharma partners, signing a deal with Eli Lilly that includes a $115m upfront payment. M&A / DealsRead full story Post navigation Previous: S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLCNext: Otsuka grows in neuroplastogens with $1.225bn Transcend buy Related Stories M&A / Deals Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B pharminent May 13, 2026 M&A / Deals BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal pharminent May 12, 2026 M&A / Deals Cellular Intelligence scoops up Novo’s Parkinson’s therapy pharminent May 12, 2026
